L. Martinezmartinez et al., COMPARATIVE IN-VITRO ACTIVITIES OF NEW QUINOLONES AGAINST CORYNEFORM BACTERIA, Antimicrobial agents and chemotherapy, 38(6), 1994, pp. 1439-1441
The in vitro activities of eight quinolones against 115 coryneform bac
teria (20 Corynebacterium jeikeium, 15 Corynebacterium minutissimum, 1
5 Corynebacterium striatum, 25 Corynebacterium urealyticum, 10 Coryneb
acterium xerosis, 10 Corynebacterium group ANF-1, 10 Corynebacterium g
roup 12, and 10 Listeria monocytogenes) were determined. The MICs of c
iprofloxacin, ofloxacin, and sparfloxacin for 90% of C. jeikeuim, C. u
realyticum, and C. xerosis isolates tested were >16 mu g/ml. Those of
BAY Y 3118 and clinafloxacin against these species were 0.5 and 1 to 2
mu g/ml, respectively. The MICs for 90% of all 115 strains tested wer
e 0.5 mu g/ml for BAY Y 3118, 1 mu g/ml for clinafloxacin, 2 mu g/ml f
or E-5068, 4 mu g/ml for E-5065, and >16 mu g/ml for ciprofloxacin, of
loxacin, sparfloxacin, and E-4868.